Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Jan 26, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the number of adults with type 1 diabetes who are also overweight or obese. Researchers at the University Hospitals of Leuven have set up a registry to better understand how these patients respond to different treatments. The goal is to gather information that can help improve care and outcomes for individuals with both type 1 diabetes and obesity.
If you're an adult with type 1 diabetes and are interested in participating, you'll need to sign a consent form showing you understand the study. The trial is currently recruiting participants of all genders, and there are no specific age restrictions. By joining, you can contribute to important research that could lead to better treatment options for people in similar situations. Participants will be closely monitored, and their health outcomes will be studied over time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed informed consent
- • Type 1 Diabetes
About Universitaire Ziekenhuizen Ku Leuven
Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials